Using both "relative risk reduction" and "number needed to treat" in evaluating primary and secondary clinical trials of lipid regulation (vol 87, pg1206, 2001)
Pm. Moriarty, Using both "relative risk reduction" and "number needed to treat" in evaluating primary and secondary clinical trials of lipid regulation (vol 87, pg1206, 2001), AM J CARD, 88(11), 2001, pp. 1349-1350
Citations number
1
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research